| Acute kidney injury in dengue fever using Acute Kidney Injury Network criteria: incidence and risk factors N Mehra, A Patel, G Abraham, YNV Reddy, YNV Reddy Tropical doctor 42 (3), 160-162, 2012 | 89 | 2012 |
| Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy–induced vomiting in children: An open‐label, randomized phase 3 trial V Radhakrishnan, V Pai, S Rajaraman, N Mehra, T Ganesan, ... Pediatric Blood & Cancer 67 (9), e28532, 2020 | 25 | 2020 |
| COVID19 in children with cancer in low-and middle-income countries: experience from a cancer center in Chennai, India V Radhakrishnan, J Ovett, A Rajendran, S Kolluru, V Pai, V Gnanaguru, ... Pediatric Hematology and Oncology 38 (2), 161-167, 2020 | 20 | 2020 |
| Development of national cancer database for cost and quality of life (CaDCQoL) in India: a protocol S Prinja, J Dixit, N Gupta, N Mehra, A Singh, MN Krishnamurthy, D Gupta, ... BMJ open 11 (7), e048513, 2021 | 19 | 2021 |
| Virilizing ovarian steroid cell tumor in a 40 year old South Indian female: a case report S Salim, GPS Shantha, AD Patel, AA Kumar, P Ganeshram, N Mehra, ... Cases Journal 2, 1-5, 2009 | 19 | 2009 |
| Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy N Mehra, P Ganesan, TS Ganesan, S Veeriah, A Boopathy, ... Medical Oncology 35, 1-7, 2018 | 18 | 2018 |
| Genetic counseling, testing, and management of HBOC in India: an expert consensus document from Indian Society of Medical and Pediatric Oncology H Malhotra, P Kowtal, N Mehra, R Pramank, R Sarin, T Rajkumar, S Gupta, ... JCO Global Oncology 6, 991-1008, 2020 | 16 | 2020 |
| Outcomes of intensive treatment of adult acute myeloid leukemia patients: a retrospective study from a single centre JP Kalaiyarasi, P Ganesan, K Kannan, TS Ganesan, V Radhakrishnan, ... Indian Journal of Hematology and Blood Transfusion 35, 248-254, 2019 | 16 | 2019 |
| Financial toxicity of cancer treatment in India: towards closing the cancer care gap S Prinja, J Dixit, N Gupta, A Dhankhar, AC Kataki, PS Roy, N Mehra, ... Frontiers in Public Health 11, 1065737, 2023 | 14 | 2023 |
| Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers K Kumar, V Radhakrishnan, M Dhanushkodi, JP Kalaiyarasi, N Mehra, ... Cancer Research, Statistics, and Treatment 3 (1), 64-68, 2020 | 14 | 2020 |
| Evaluation of cytogenetic abnormalities in patients with acute lymphoblastic leukemia P Reddy, R Shankar, T Koshy, V Radhakrishnan, P Ganesan, ... Indian Journal of Hematology and Blood Transfusion 35, 640-648, 2019 | 14 | 2019 |
| Outcomes in adolescent and young adult acute lymphoblastic leukaemia: a report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC) P Ganesan, H Jain, B Bagal, PG Subramanian, B George, A Korula, ... British journal of haematology 193 (1), e1, 2021 | 13 | 2021 |
| Economic perspective of cancer treatment in India A Natarajan, N Mehra, T Rajkumar Medical Oncology 37 (11), 101, 2020 | 12 | 2020 |
| Chronic myeloid leukemia: long-term outcome data in the imatinib era P Ganesan, TS Ganesan, V Radhakrishnan, TG Sagar, K Kannan, ... Indian Journal of Hematology and Blood Transfusion 35, 37-42, 2019 | 11 | 2019 |
| Fulvestrant in hormone-positive advanced breast cancer: Real-world outcome IM Vaikundaraja, M Dhanushkodi, V Radhakrishnan, JP Kalaiarasi, ... Cancer Research, Statistics, and Treatment 3 (2), 275-280, 2020 | 10 | 2020 |
| Gemcitabine, vinorelbine and dexamethasone: a safe and effective regimen for treatment of relapsed/refractory hodgkin’s lymphoma P Ganesan, N Mehra, A Joel, V Radhakrishnan, M Dhanushkodi, ... Leukemia Research 84, 106188, 2019 | 10 | 2019 |
| Is there a genetic predisposition to new-onset diabetes after kidney transplantation? YNV Reddy, G Abraham, V Sundaram, PP Reddy, M Mathew, ... Saudi Journal of Kidney Diseases and Transplantation 26 (6), 1113-1120, 2015 | 10 | 2015 |
| Cost effectiveness of bevacizumab plus chemotherapy for the treatment of advanced and metastatic cervical cancer in India—a model-based economic analysis N Gupta, P Nehra, AS Chauhan, N Mehra, A Singh, MN Krishnamurthy, ... JCO Global Oncology 8, e2100355, 2022 | 9 | 2022 |
| Cost-effectiveness of the first line treatment options for metastatic renal cell carcinoma in India D Gupta, A Singh, N Gupta, N Mehra, P Bahuguna, V Aggarwal, ... JCO Global Oncology 9, e2200246, 2023 | 8 | 2023 |
| Cost effectiveness of Ribociclib and Palbociclib in the second-line treatment of hormone receptor-positive, HER2-negative metastatic breast Cancer in post-menopausal Indian women N Gupta, D Gupta, J Dixit, N Mehra, A Singh, MN Krishnamurthy, G Jyani, ... Applied Health Economics and Health Policy 20 (4), 609-621, 2022 | 8 | 2022 |
